Clinical Trials Logo

Clinical Trial Summary

Anthocyanins, the water-soluble compounds that make plants appear different colors, have been shown to prevent insulin resistance, reduce the blood glucose and oxidative stress in rodents. The purpose of our study is to evaluate a potential protective effect of purified anthocyanins supplement on type 2 diabetes mellitus patients.


Clinical Trial Description

The study was designed as a randomized, double-blind label, interventional study on patients with T2DM. The eligible Participants are randomly assigned to control and Anthocyanins supplement group. During the 12 weeks trial period,the participants were instructed to consume two anthocyanin capsules or placebo capsules twice daily (30 min after breakfast and supper). ;


Study Design

Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Outcomes Assessor), Primary Purpose: Treatment


Related Conditions & MeSH terms


NCT number NCT02317211
Study type Interventional
Source Sun Yat-sen University
Contact
Status Completed
Phase Phase 0
Start date February 2014
Completion date September 2014

See also
  Status Clinical Trial Phase
Completed NCT04913909 - Effects of a Probiotic on Oral Microbiota and Glycemic Control in Type 2 Diabetics; A Randomized Clinical Trial N/A
Completed NCT02650726 - Purified Anthocyanins Supplementation and High-Density Lipoprotein (HDL) Function Phase 0